Related Experiment Video
Updated: Feb 26, 2026

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Pediatric Human Immunodeficiency Virus Continuum of Care: A Concise Review of Evidence-Based Practice
Megan E Gray1, Phillip Nieburg2, Rebecca Dillingham1
1Division of Infectious Diseases and International Health, University of Virginia, PO Box 801340, Charlottesville, VA 22908-1340, USA.
Insights
Caring for children and adolescents with human immunodeficiency virus (HIV) requires unique strategies. Addressing age-specific barriers to antiretroviral therapy (ART) is crucial for sustained viral suppression and a normal lifespan.
Area of Science:
- Pediatric infectious diseases
- Adolescent medicine
- Public health
Background:
- Children and adolescents with HIV require specialized care approaches.
- Key stages include prevention, testing, antiretroviral therapy (ART) initiation, and ongoing engagement.
- Age-specific barriers must be addressed for successful long-term viral suppression.
Purpose of the Study:
- To highlight the unique challenges and necessary strategies in providing HIV care for pediatric and adolescent populations.
- To emphasize the importance of addressing age-specific barriers throughout the continuum of HIV care.
- To underscore the potential for a normal lifespan with sustained ART.
Main Methods:
- This is a review and synthesis of current knowledge and best practices in pediatric and adolescent HIV care.
- Focuses on critical steps: prevention, testing, ART initiation, retention, and engagement.
- Examines common struggles such as ART adherence, disclosure, and stigma.
Main Results:
- Successful HIV care for youth necessitates addressing unique age-related barriers.
- Adherence to ART, disclosure of HIV status, and stigma are significant challenges for youth, families, and providers.
- Multifaceted approaches and careful care transitions are essential.
Conclusions:
- With sustained antiretroviral therapy (ART), youth living with HIV can achieve long-term health and a normal lifespan.
- Effective HIV management in young people requires tailored strategies and comprehensive support.
- Continued research and implementation of best practices are vital for improving outcomes.
Abstract:
Children and adolescents living with human immunodeficiency virus (HIV) represent a population that requires a unique approach to HIV care. Prevention, testing, initiation of antiretroviral therapy (ART), and retention and engagement in care are critical steps. Each step requires providers to address age-specific barriers, so that successful and prolonged viral suppression can occur. Adherence to ART, disclosure of HIV-positive status, and stigma are examples of struggles faced by youth, their families, and health care providers. A multifaceted approach and thoughtful transitions of care are needed, but with sustained ART, youth living with HIV can survive and thrive with the expectation of a normal lifespan.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

